Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within Angiopoietin receptor Tie2-mediated signaling 161.0 14194.0 88.0 -0.71 0.075 1000.0 -1000.0 -0.062 -1000.0 Signaling events mediated by the Hedgehog family 143.0 7466.0 52.0 -0.438 0.23 1000.0 -1000.0 -0.038 -1000.0 Endothelins 93.0 8967.0 96.0 -0.377 0.106 1000.0 -1000.0 -0.054 -1000.0 Fc-epsilon receptor I signaling in mast cells 67.0 6585.0 97.0 -0.145 0.023 1000.0 -1000.0 -0.059 -1000.0 Thromboxane A2 receptor signaling 61.0 6430.0 105.0 -0.201 0.055 1000.0 -1000.0 -0.039 -1000.0 IL4-mediated signaling events 59.0 5438.0 91.0 -0.806 0.486 1000.0 -1000.0 -0.116 -1000.0 Aurora B signaling 59.0 3953.0 67.0 -0.297 0.286 1000.0 -1000.0 -0.029 -1000.0 Signaling mediated by p38-alpha and p38-beta 56.0 2486.0 44.0 -0.106 0.022 1000.0 -1000.0 -0.028 -1000.0 amb2 Integrin signaling 55.0 4536.0 82.0 -0.501 0.035 1000.0 -1000.0 -0.04 -1000.0 TCGA08_retinoblastoma 55.0 443.0 8.0 -0.01 0.096 1000.0 -1000.0 -0.002 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 52.0 2722.0 52.0 -0.261 0.048 1000.0 -1000.0 -0.042 -1000.0 Aurora C signaling 50.0 353.0 7.0 -0.0 0.151 1000.0 -1000.0 -0.013 -1000.0 Signaling events regulated by Ret tyrosine kinase 41.0 3427.0 82.0 -0.111 0.055 1000.0 -1000.0 -0.061 -1000.0 Nongenotropic Androgen signaling 38.0 1980.0 52.0 -0.112 0.075 1000.0 -1000.0 -0.033 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 38.0 2964.0 78.0 -0.155 0.05 1000.0 -1000.0 -0.049 -1000.0 BMP receptor signaling 37.0 3077.0 81.0 -0.274 0.148 1000.0 -1000.0 -0.044 -1000.0 Integrins in angiogenesis 35.0 2952.0 84.0 -0.331 0.127 1000.0 -1000.0 -0.044 -1000.0 Calcium signaling in the CD4+ TCR pathway 35.0 1112.0 31.0 -0.171 0.024 1000.0 -1000.0 -0.039 -1000.0 Arf6 signaling events 33.0 2075.0 62.0 -0.135 0.043 1000.0 -1000.0 -0.041 -1000.0 PLK1 signaling events 33.0 2828.0 85.0 -0.027 0.156 1000.0 -1000.0 -0.025 -1000.0 Canonical Wnt signaling pathway 30.0 1544.0 51.0 -0.337 0.155 1000.0 -1000.0 -0.045 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 29.0 3720.0 125.0 -0.13 0.051 1000.0 -1000.0 -0.052 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 28.0 1962.0 68.0 -0.182 0.04 1000.0 -1000.0 -0.072 -1000.0 Presenilin action in Notch and Wnt signaling 27.0 1653.0 61.0 -0.338 0.155 1000.0 -1000.0 -0.041 -1000.0 Reelin signaling pathway 27.0 1556.0 56.0 -0.068 0.059 1000.0 -1000.0 -0.052 -1000.0 Glypican 2 network 27.0 108.0 4.0 0.028 0.057 1000.0 -1000.0 0.013 -1000.0 IL6-mediated signaling events 27.0 2071.0 75.0 -0.461 0.048 1000.0 -1000.0 -0.066 -1000.0 Coregulation of Androgen receptor activity 26.0 1978.0 76.0 -0.324 0.095 1000.0 -1000.0 -0.027 -1000.0 Visual signal transduction: Cones 25.0 967.0 38.0 -0.04 0.126 1000.0 -1000.0 -0.026 -1000.0 Syndecan-3-mediated signaling events 25.0 893.0 35.0 -0.244 0.056 1000.0 -1000.0 -0.027 -1000.0 FOXM1 transcription factor network 25.0 1316.0 51.0 0.022 0.35 1000.0 -1000.0 -0.122 -1000.0 LPA4-mediated signaling events 24.0 289.0 12.0 -0.098 -0.0 1000.0 -1000.0 -0.025 -1000.0 IL23-mediated signaling events 24.0 1481.0 60.0 -0.196 0.023 1000.0 -1000.0 -0.115 -1000.0 HIF-1-alpha transcription factor network 23.0 1750.0 76.0 -0.108 0.138 1000.0 -1000.0 -0.109 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 23.0 2025.0 85.0 -0.103 0.031 1000.0 -1000.0 -0.044 -1000.0 FOXA2 and FOXA3 transcription factor networks 23.0 1084.0 46.0 -0.69 0.106 1000.0 -1000.0 -0.115 -1000.0 TCR signaling in naïve CD8+ T cells 23.0 2153.0 93.0 -0.06 0.032 1000.0 -1000.0 -0.048 -1000.0 Plasma membrane estrogen receptor signaling 23.0 1997.0 86.0 -0.11 0.038 1000.0 -1000.0 -0.052 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 23.0 760.0 33.0 -0.164 0.095 1000.0 -1000.0 -0.025 -1000.0 Regulation of Androgen receptor activity 23.0 1615.0 70.0 -0.352 0.144 1000.0 -1000.0 -0.042 -1000.0 Glucocorticoid receptor regulatory network 22.0 2580.0 114.0 -0.326 0.074 1000.0 -1000.0 -0.057 -1000.0 IL12-mediated signaling events 21.0 1864.0 87.0 -0.176 0.044 1000.0 -1000.0 -0.078 -1000.0 Syndecan-1-mediated signaling events 21.0 734.0 34.0 -0.09 0.151 1000.0 -1000.0 -0.048 -1000.0 Nectin adhesion pathway 20.0 1292.0 63.0 -0.031 0.125 1000.0 -1000.0 -0.042 -1000.0 Wnt signaling 20.0 145.0 7.0 0.007 0.056 1000.0 -1000.0 -0.015 -1000.0 Caspase cascade in apoptosis 19.0 1408.0 74.0 -0.068 0.083 1000.0 -1000.0 -0.031 -1000.0 ErbB4 signaling events 19.0 1351.0 69.0 -0.129 0.165 1000.0 -1000.0 -0.05 -1000.0 Glypican 1 network 19.0 950.0 48.0 -0.137 0.086 1000.0 -1000.0 -0.031 -1000.0 S1P1 pathway 18.0 657.0 36.0 -0.105 0.022 1000.0 -1000.0 -0.04 -1000.0 FAS signaling pathway (CD95) 18.0 863.0 47.0 -0.2 0.061 1000.0 -1000.0 -0.035 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 17.0 941.0 54.0 -0.068 0.072 1000.0 -1000.0 -0.055 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 17.0 2117.0 120.0 -0.14 0.06 1000.0 -1000.0 -0.046 -1000.0 TCGA08_p53 16.0 118.0 7.0 -0.03 0.022 1000.0 -1000.0 -0.014 -1000.0 Visual signal transduction: Rods 16.0 851.0 52.0 -0.04 0.093 1000.0 -1000.0 -0.036 -1000.0 JNK signaling in the CD4+ TCR pathway 14.0 251.0 17.0 -0.035 0.032 1000.0 -1000.0 -0.035 -1000.0 p75(NTR)-mediated signaling 14.0 1821.0 125.0 -0.049 0.147 1000.0 -1000.0 -0.075 -1000.0 PDGFR-alpha signaling pathway 14.0 627.0 44.0 -0.13 0.046 1000.0 -1000.0 -0.042 -1000.0 Ras signaling in the CD4+ TCR pathway 14.0 240.0 17.0 -0.017 0.031 1000.0 -1000.0 -0.025 -1000.0 Noncanonical Wnt signaling pathway 13.0 362.0 26.0 -0.052 0.056 1000.0 -1000.0 -0.045 -1000.0 Signaling events mediated by PTP1B 13.0 1028.0 76.0 -0.047 0.057 1000.0 -1000.0 -0.036 -1000.0 Effects of Botulinum toxin 13.0 338.0 26.0 -0.036 0.03 1000.0 -1000.0 -0.017 -1000.0 BCR signaling pathway 13.0 1340.0 99.0 -0.089 0.053 1000.0 -1000.0 -0.053 -1000.0 S1P4 pathway 13.0 331.0 25.0 -0.029 0.032 1000.0 -1000.0 -0.026 -1000.0 Osteopontin-mediated events 12.0 473.0 38.0 -0.047 0.13 1000.0 -1000.0 -0.048 -1000.0 Aurora A signaling 12.0 734.0 60.0 -0.04 0.206 1000.0 -1000.0 -0.027 -1000.0 Ephrin B reverse signaling 12.0 604.0 48.0 -0.058 0.063 1000.0 -1000.0 -0.03 -1000.0 EGFR-dependent Endothelin signaling events 12.0 266.0 21.0 -0.025 0.049 1000.0 -1000.0 -0.044 -1000.0 Regulation of nuclear SMAD2/3 signaling 11.0 1515.0 136.0 -0.204 0.145 1000.0 -1000.0 -0.041 -1000.0 Sphingosine 1-phosphate (S1P) pathway 11.0 320.0 28.0 -0.11 0.043 1000.0 -1000.0 -0.031 -1000.0 Hedgehog signaling events mediated by Gli proteins 11.0 753.0 65.0 -0.519 0.055 1000.0 -1000.0 -0.039 -1000.0 mTOR signaling pathway 11.0 589.0 53.0 -0.018 0.092 1000.0 -1000.0 -0.039 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 11.0 848.0 74.0 -0.138 0.049 1000.0 -1000.0 -0.071 -1000.0 HIF-2-alpha transcription factor network 10.0 464.0 43.0 -0.072 0.074 1000.0 -1000.0 -0.062 -1000.0 Syndecan-4-mediated signaling events 10.0 692.0 67.0 -0.032 0.086 1000.0 -1000.0 -0.043 -1000.0 Syndecan-2-mediated signaling events 9.0 677.0 69.0 -0.034 0.086 1000.0 -1000.0 -0.041 -1000.0 Cellular roles of Anthrax toxin 9.0 351.0 39.0 -0.06 0.023 1000.0 -1000.0 -0.022 -1000.0 Retinoic acid receptors-mediated signaling 9.0 522.0 58.0 -0.155 0.045 1000.0 -1000.0 -0.036 -1000.0 LPA receptor mediated events 9.0 947.0 102.0 -0.061 0.041 1000.0 -1000.0 -0.055 -1000.0 ErbB2/ErbB3 signaling events 8.0 552.0 65.0 -0.038 0.033 1000.0 -1000.0 -0.058 -1000.0 IL2 signaling events mediated by PI3K 8.0 466.0 58.0 -0.02 0.117 1000.0 -1000.0 -0.038 -1000.0 EPHB forward signaling 8.0 685.0 85.0 -0.043 0.072 1000.0 -1000.0 -0.069 -1000.0 Regulation of p38-alpha and p38-beta 8.0 435.0 54.0 -0.043 0.053 1000.0 -1000.0 -0.046 -1000.0 IL27-mediated signaling events 8.0 446.0 51.0 -0.068 0.029 1000.0 -1000.0 -0.049 -1000.0 IL2 signaling events mediated by STAT5 8.0 182.0 22.0 0.004 0.076 1000.0 -1000.0 -0.039 -1000.0 IGF1 pathway 8.0 459.0 57.0 -0.055 0.058 1000.0 -1000.0 -0.053 -1000.0 PDGFR-beta signaling pathway 8.0 808.0 97.0 -0.046 0.066 1000.0 -1000.0 -0.057 -1000.0 TCGA08_rtk_signaling 7.0 196.0 26.0 -0.064 0.081 1000.0 -1000.0 -0.016 -1000.0 Insulin Pathway 7.0 525.0 74.0 -0.089 0.06 1000.0 -1000.0 -0.061 -1000.0 IFN-gamma pathway 6.0 444.0 68.0 -0.027 0.066 1000.0 -1000.0 -0.057 -1000.0 Ceramide signaling pathway 6.0 522.0 76.0 -0.012 0.06 1000.0 -1000.0 -0.032 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 6.0 561.0 83.0 -0.067 0.041 1000.0 -1000.0 -0.039 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 6.0 306.0 45.0 -0.019 0.051 1000.0 -1000.0 -0.051 -1000.0 Class I PI3K signaling events 6.0 467.0 73.0 -0.029 0.042 1000.0 -1000.0 -0.044 -1000.0 S1P3 pathway 6.0 274.0 42.0 -0.11 0.043 1000.0 -1000.0 -0.041 -1000.0 Signaling events mediated by PRL 6.0 229.0 34.0 -0.036 0.064 1000.0 -1000.0 -0.048 -1000.0 E-cadherin signaling in keratinocytes 6.0 260.0 43.0 -0.05 0.063 1000.0 -1000.0 -0.042 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 5.0 171.0 34.0 -0.032 0.051 1000.0 -1000.0 -0.033 -1000.0 Ephrin A reverse signaling 5.0 37.0 7.0 -0.011 0.03 1000.0 -1000.0 -0.022 -1000.0 EPO signaling pathway 5.0 276.0 55.0 -0.011 0.06 1000.0 -1000.0 -0.05 -1000.0 Signaling events mediated by HDAC Class III 5.0 203.0 40.0 -0.079 0.042 1000.0 -1000.0 -0.031 -1000.0 TRAIL signaling pathway 5.0 263.0 48.0 -0.037 0.059 1000.0 -1000.0 -0.029 -1000.0 ceramide signaling pathway 5.0 273.0 49.0 -0.0 0.033 1000.0 -1000.0 -0.033 -1000.0 Signaling events mediated by HDAC Class I 5.0 533.0 104.0 -0.043 0.055 1000.0 -1000.0 -0.034 -1000.0 Signaling events mediated by HDAC Class II 4.0 307.0 75.0 -0.034 0.056 1000.0 -1000.0 -0.036 -1000.0 BARD1 signaling events 4.0 244.0 57.0 -0.042 0.089 1000.0 -1000.0 -0.037 -1000.0 IL1-mediated signaling events 4.0 268.0 62.0 -0.02 0.041 1000.0 -1000.0 -0.059 -1000.0 FoxO family signaling 4.0 258.0 64.0 -0.022 0.072 1000.0 -1000.0 -0.057 -1000.0 E-cadherin signaling in the nascent adherens junction 4.0 325.0 76.0 -0.013 0.06 1000.0 -1000.0 -0.061 -1000.0 VEGFR1 specific signals 4.0 266.0 56.0 -0.13 0.056 1000.0 -1000.0 -0.048 -1000.0 a4b1 and a4b7 Integrin signaling 3.0 17.0 5.0 0.017 0.028 1000.0 -1000.0 0.007 -1000.0 Insulin-mediated glucose transport 3.0 97.0 32.0 -0.009 0.043 1000.0 -1000.0 -0.031 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 3.0 124.0 37.0 -0.013 0.052 1000.0 -1000.0 -0.032 -1000.0 Regulation of Telomerase 3.0 374.0 102.0 -0.041 0.068 1000.0 -1000.0 -0.05 -1000.0 p38 MAPK signaling pathway 3.0 149.0 44.0 -0.003 0.054 1000.0 -1000.0 -0.028 -1000.0 Canonical NF-kappaB pathway 2.0 102.0 39.0 -0.006 0.046 1000.0 -1000.0 -0.03 -1000.0 Arf6 downstream pathway 2.0 115.0 43.0 -0.045 0.046 1000.0 -1000.0 -0.023 -1000.0 Class I PI3K signaling events mediated by Akt 2.0 155.0 68.0 -0.034 0.048 1000.0 -1000.0 -0.042 -1000.0 Paxillin-dependent events mediated by a4b1 2.0 98.0 36.0 -0.041 0.043 1000.0 -1000.0 -0.038 -1000.0 Arf6 trafficking events 2.0 196.0 71.0 -0.055 0.04 1000.0 -1000.0 -0.035 -1000.0 Circadian rhythm pathway 1.0 29.0 22.0 -0.006 0.048 1000.0 -1000.0 -0.034 -1000.0 S1P5 pathway 1.0 32.0 17.0 -0.015 0.03 1000.0 -1000.0 -0.013 -1000.0 Signaling mediated by p38-gamma and p38-delta 1.0 27.0 15.0 -0.011 0.022 1000.0 -1000.0 -0.031 -1000.0 Rapid glucocorticoid signaling 1.0 31.0 20.0 -0.011 0.024 1000.0 -1000.0 -0.012 -1000.0 Class IB PI3K non-lipid kinase events 1.0 3.0 3.0 -0.021 0.021 1000.0 -1000.0 -0.008 -1000.0 Arf1 pathway 1.0 71.0 54.0 -0.005 0.031 1000.0 -1000.0 -0.019 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0 12.0 23.0 0.003 0.042 1000.0 -1000.0 -0.029 -1000.0 PLK2 and PLK4 events 0.0 1.0 3.0 -0.01 0.022 1000.0 -1000.0 -0.032 -1000.0 Atypical NF-kappaB pathway 0.0 13.0 31.0 -0.008 0.023 1000.0 -1000.0 -0.029 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 10.0 27.0 -0.01 0.053 1000.0 -1000.0 -0.041 -1000.0 E-cadherin signaling events 0.0 0.0 5.0 0.021 0.042 1000.0 -1000.0 0.01 -1000.0 Alternative NF-kappaB pathway 0.0 4.0 13.0 0.0 0.06 1000.0 -1000.0 0.0 -1000.0 Total 2465 159775 7203 -14.2962428751 9.53910428448 131000 -131000 -5.41761685503 -131000